Lansoprazole Laboratorios Liconsa S.A (Lansoprazole)

Lansoprazole inhibits the H+/K+ ATPase pump, also known as the gastric proton pump, on the secretory surface of parietal cells. This irreversible blockade prevents the final step of acid secretion, leading to a sustained increase in gastric pH and allowing ulcerated or inflamed mucosa to heal.

The appropriate dose of Lansoprazole Laboratorios Liconsa S.A is determined by the prescribing healthcare professional based on the specific indication, patient age, renal function, and other clinical factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for Lansoprazole during pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers will evaluate the individual situation before prescribing.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. The sales team will then respond with pricing, availability, shipping details and any required import documentation.

Lansoprazole belongs to the same class as omeprazole, esomeprazole and pantoprazole. All PPIs share a similar mechanism of action, but they differ slightly in pharmacokinetic profiles, potency and drug‑interaction potential. Lansoprazole is often chosen for its once‑daily dosing convenience and a favorable safety record in clinical practice.

Store the product at room temperature, below 25 °C, in the original packaging to protect it from moisture and light. Do not store in a bathroom or near a heat source. Keep out of reach of children and discard any tablets that appear discoloured or damaged.

Lansoprazole is taken orally, usually as a whole tablet swallowed with a glass of water. It can be taken with or without food, but consistent timing each day improves effectiveness. Patients should not crush, chew, or split the tablet unless specifically instructed by a healthcare professional.

Serious adverse events, although rare, include severe allergic reactions such as anaphylaxis or angioedema, hypomagnesemia with prolonged use, and Clostridioides difficile‑associated colitis. Long‑term therapy may also increase the risk of bone fractures, especially in elderly patients.

Patients with a known hypersensitivity to lansoprazole, other proton pump inhibitors, or any of the tablet’s excipients should avoid the drug. Caution is advised in individuals with severe hepatic impairment, and the medication should be used only under medical supervision in such cases.